患者报告结局指标在关节置换术后两年提供很少额外价值:一项系统综述与Meta分析
该系统综述与Meta分析纳入24项报告患者报告结局指标(PROM)的随机对照试验,评估全膝关节置换(TKA)和全髋关节置换(THA)术后最常报告的PROM、≥5年随访时PROM数据的完整性以及早期与长期随访间评分的变化。结果显示TKA的OKS、WOMAC等评分在术后1–2年即进入平台期,此后变化很小;长期PROM数据常不完整且失去敏感性,作者认为应考虑放弃对长期PROM采集的要求。
要点
- TKA最常报告的PROM为牛津膝关节评分(OKS),THA为加州大学洛杉矶分校活动量表。
- TKA的OKS短期随访平均变化为-16.3分(95%CI -17.5至-15.2),剩余随访仅1.3分(95%CI -0.8至3.3)。
- 基于最终随访可用患者数的平均随访率膝关节为70.5%(39.2%至91.0%),髋关节为82.1%(63.2%至92.3%),实际PROM采集率更低。
核心结论
- TKA和THA术后超过1–2年的长期PROM常不完整,且在此时间点后失去敏感性。
- 鉴于采集这些评分需要大量资源、成本与挑战,其临床价值存疑。
- 作者认为应考虑放弃对长期PROM采集的要求,转而采用更稳健、可靠且更具临床相关性和实用性的成功衡量指标。
研究设计与样本
- 系统综述与Meta分析,纳入报告PROM充分的随机对照试验(RCT),共评估24项研究。
- 计算从术前到早期随访(1至2年间)以及从早期到最终随访的评分平均差值,并由代表性研究计算评分的平均变化率。
- 对最常报告的PROM进行Meta分析。
主要发现
- TKA最常报告的PROM为牛津膝关节评分(OKS),THA为加州大学洛杉矶分校(UCLA)活动量表。
- 基于最终随访可用患者数的平均随访率:膝关节70.5%(39.2%至91.0%),髋关节82.1%(63.2%至92.3%);实际PROM评分采集率更低。
- TKA短期随访(术前至早期)平均变化:OKS -16.3分(95%CI -17.5至-15.2),WOMAC 23.2分(95%CI 17.2至29.2),转换后WOMAC -29.7分(95%CI -32.4至-27.0)。
- TKA剩余随访(早期至最终)平均变化:OKS 1.3分(95%CI -0.8至3.3),WOMAC -3.4分(95%CI -7.0至0.3),转换后WOMAC 4.7分(95%CI -1.5至10.9)。
- THA研究无法进行类似的Meta分析;常见观察到评分在1至2年后进入平台期,此后变化很小或无变化。
临床怎么用
- 作者认为长期PROM在TKA和THA术后1–2年后常不完整且失去敏感性,其临床价值存疑。
- 作者认为应考虑放弃对长期PROM采集的要求,转而采用更稳健、可靠且更具临床相关性和实用性的成功衡量指标。
局限性
- THA研究无法进行类似的Meta分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The use of patient-reported outcome measures (PROMs) to assess the outcome after total knee (TKA) and total hip arthroplasty (THA) is increasing, with associated regulatory mandates. However, the robustness and clinical relevance of long-term data are often questionable. It is important to determine whether using long-term PROMs data justify the resources, costs, and difficulties associated with their collection. The aim of this study was to assess studies involving TKA and THA to determine which PROMs are most commonly reported, how complete PROMs data are at ≥ five years postoperatively, and the extent to which the scores change between early and long-term follow-up. METHODS: We conducted a systematic review of the literature. Randomized controlled trials (RCTs) with sufficient reporting of PROMs were included. The mean difference in scores from the preoperative condition to early follow-up times (between one and two years), and from early to final follow-up, were calculated. The mean rates of change in the scores were calculated from representative studies. Meta-analyses were also performed on the most frequently reported PROMs. RESULTS: A total of 24 studies were assessed. The most frequently reported PROMs were the Oxford Knee Score (OKS) for TKA and the University of California, Los Angeles activity scale for THA. The mean rate of follow-up based on the number of patients available at final follow-up was 70.5% (39.2% to 91.0%) for knees and 82.1% (63.2% to 92.3%) for hips. The actual rates of collection of PROM scores were lower. For TKA, the mean OKS, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and transformed WOMAC changes were -16.3 (95% CI -17.5 to -15.2), 23.2 (95% CI 17.2 to 29.2), and -29.7 (95% CI -32.4 to -27.0) points for short-term follow-up. These decreased to 1.3 (95% CI -0.8 to 3.3), -3.4 (95% CI -7.0 to 0.3), and 4.7 (95% CI -1.5 to 10.9) points for the remaining follow-up. A similar meta-analysis was not possible for studies involving THA. We commonly observed that the scores plateaued after between one and two years, and that there was little or no change beyond this time. CONCLUSION: The long-term PROMs for TKA and THA beyond one or two years are often incomplete and lose sensitivity at this time. Given the considerable resources, costs, and challenges associated with the collection of these scores, their clinical value is questionable. Therefore, consideration should be given to abandoning the requirement for the collection of long-term PROMs in favour of more robust and reliable measures of success that offer more clinical relevance and use.
引用
- Spece H, Kurtz MA, Piuzzi NS, et al. Patient-reported outcome measures offer little additional value two years after arthroplasty : a systematic review and meta-analysis. Bone Joint J. 2025. PMID: 40025985. doi:10.1302/0301-620X.107B3.BJJ-2024-0910.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。